Diego Gonzalez, MD
Interventional Pain Medicine · Albuquerque, NMNPI 1194715938
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 56.6% of the total. Reporting peaked in 2022 at $13,623 and has fallen 79.5% since, to $2,792 in 2025.
Across 386 payments — averaging $89.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Nevro Corp.$6K
- Nalu Medical, Inc.$2K
- Boston Scientific$2K
- Orthofix Medical, Inc.$1K
- Relievant Medsystems, Inc.$1K
- plus $1K from 17 others
What the payments were for
- Consulting fees$4,00012%
- Speaking & faculty fees$10,23030%
- Travel & lodging$8,85226%
- Food & beverage$11,51233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 143 | $19,590 |
| Nevro Corp. | 104 | $6,415 |
| Nalu Medical, Inc. | 38 | $2,451 |
| Boston Scientific | 25 | $2,248 |
| Orthofix Medical, Inc. | 7 | $1,319 |
| Relievant Medsystems, Inc. | 13 | $1,165 |
| Globus Medical | 25 | $633 |
| Biodelivery Sciences International, Inc. | 8 | $129 |
| Stryker | 1 | $123 |
| Curonix LLC | 1 | $98 |
| Abbott | 2 | $64 |
| Si-bone, Inc. | 2 | $64 |
| Baxter Healthcare | 2 | $43 |
| Piramal Critical Care | 1 | $39 |
| Pfizer | 3 | $36 |
| GRT US Holding, Inc. | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Avanos Medical | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| MDD US Operations, LLC | 1 | $15 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$10,818
- Intracept$4,444
- Senza Spinal Cord Stimulation System$4,169
- SYNCHROMED$2,277
- Nalu Neurostimulation System$1,948
- INTELLIS ADAPTIVESTIM$1,270
- FORZA$1,172
- KYPHON EXPRESS II KYPHOPAK TRAY$814
- Firebird$723
- SUPERION$678
- RESTORE$604
- SambaScrew$449
- ADAPTIVESTIM$349
- Senza$295
- INCEPTIV$281
- Omnia$233
- OSTEOCOOL RF ABLATION SYSTEM$144
- IVS - MULTIGEN RF$123
- Vanta$107
How this compares
Too few interventional pain medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 18 | $401 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Albuquerque
- Reuel MeasomAlbuquerque$49K
- Athanasios ManoleAlbuquerque$9K
- Craig NairnAlbuquerque$4K
- Edward PoonAlbuquerque$2K
- Kyle SchoenbergerAlbuquerque$2K
- Michael MalizzoAlbuquerque$462
- Cesar VelardeLas Cruces$3K
- Jose RamirezLas Cruces$714
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.